Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Cost-effective Analysis on Cascade Genetic Testing for Familial Hypercholesterolemia as a Preventive Measure against Cardiovascular Disease
EF 2009-10
Résumé
Familial hypercholesterolemia (FH) is a genetic disorder that affects one in every 500 people in Western populations. Characterized by elevated levels of blood cholesterol, FH patients develop arteriosclerosis over time and face higher risks of contracting cardiovascular disease (CVD), one of Canada's leading causes of death. Genetic testing for FH in the asymptomatic relatives of patients was implemented in the Netherlands in 1994, and studies have shown that early interventions with cholesterol-lowering statins in those who tested positive effectively enhanced the prospects of their lives. While these results are promising, a country-specific assessment on the feasibility and benefits of adopting such practice is necessary and yet to be performed in Canada. The proposed research aims to fill this gap and provide a comprehensive evaluation of adopting the genetic test as a health care service in Canada. To do this, three phases of research activities will be conducted. First, the total cost of initiating and maintaining the service will be assessed. This includes the cost of the genetic tests themselves but also of testing facilities, clinical personnel, and genetic counseling programs. Next, Canadians' attitudes towards the predictive genetic test will be evaluated. Willingness of the public to participate in genetic testing and take the recommended precautionary measures in the event of a positive test result is critical for the successful implementation of the test and will be assessed with questionnaire-based surveys. Lastly, a comprehensive analysis combining the first two phases with projected outcomes that early statins administration has will be performed to assess the overall effectiveness of the genetic test. In keeping up with current advances in genetics research, this project will aim to translate bench findings to clinical practices and minimize the occurrence of CVD thereby improving the quality of life for Canadians.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
197223
Name
Kim Soo-Min Joanne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Cost-effective Analysis on Cascade Genetic Testing for Familial Hypercholesterolemia as a Preventive Measure against Cardiovascular Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cardiovascular Disease; Cost Analysis; Cost-Effective Analysis; Disease Prevention; Familial Hypercholesterolemia; Genetics; Health Economics; Health Services Research
Abstract
Familial hypercholesterolemia (FH) is a genetic disorder that affects one in every 500 people in Western populations. Characterized by elevated levels of blood cholesterol, FH patients develop arteriosclerosis over time and face higher risks of contracting cardiovascular disease (CVD), one of Canada's leading causes of death. Genetic testing for FH in the asymptomatic relatives of patients was implemented in the Netherlands in 1994, and studies have shown that early interventions with cholesterol-lowering statins in those who tested positive effectively enhanced the prospects of their lives. While these results are promising, a country-specific assessment on the feasibility and benefits of adopting such practice is necessary and yet to be performed in Canada. The proposed research aims to fill this gap and provide a comprehensive evaluation of adopting the genetic test as a health care service in Canada. To do this, three phases of research activities will be conducted. First, the total cost of initiating and maintaining the service will be assessed. This includes the cost of the genetic tests themselves but also of testing facilities, clinical personnel, and genetic counseling programs. Next, Canadians' attitudes towards the predictive genetic test will be evaluated. Willingness of the public to participate in genetic testing and take the recommended precautionary measures in the event of a positive test result is critical for the successful implementation of the test and will be assessed with questionnaire-based surveys. Lastly, a comprehensive analysis combining the first two phases with projected outcomes that early statins administration has will be performed to assess the overall effectiveness of the genetic test. In keeping up with current advances in genetics research, this project will aim to translate bench findings to clinical practices and minimize the occurrence of CVD thereby improving the quality of life for Canadians.
Competitiondate
200911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kim, Soo-Min Joanne
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~